Merck & Co Inc (MRK) Q4 2024 Earnings Call Highlights: Strong Growth in Oncology and Animal ...
Merck & Co Inc (MRK) reports robust sales growth driven by KEYTRUDA and WINREVAIR, while navigating GARDASIL demand issues in China.
Merck & Co Inc (MRK) reports robust sales growth driven by KEYTRUDA and WINREVAIR, while navigating GARDASIL demand issues in China.